Table 3. Clinical features of flagged-up patients and decisions made about further clinical review.
|
Not for further review |
||||||||
|---|---|---|---|---|---|---|---|---|
| Clinical features | For further review | Previously referred | Other reasons | Total | ||||
| FOBt positive from bowel cancer screening | 7 | 7% | 84 | 89% | 3 | 3% | 94 | 100% |
| Change in bowel habit | 27 | 26% | 69 | 66% | 8 | 8% | 104 | 100% |
| Diarrhoea for ⩾6 weeks | 70 | 44% | 51 | 32% | 37 | 23% | 158 | 100% |
| Microcytic anaemia | 112 | 47% | 89 | 38% | 35 | 15% | 236 | 100% |
| Abdominal mass | 3 | 38% | 3 | 38% | 2 | 25% | 8 | 100% |
| Symptoms not collected | 3 | 75% | 1 | 25% | 0% | 4 | 100% | |
| Rectal bleeding | 52 | 25% | 131 | 64% | 22 | 11% | 205 | 100% |
| Total | 274 | 34% | 428 | 53% | 107 | 13% | 809 | 100% |
Abbreviation: FOBt=faecal occult blood test.